Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION (Tables)

v3.22.2.2
STOCK-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2022
Share-based Payment Arrangement [Abstract]  
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award The following table contains information about the Company's equity incentive plans as of June 30, 2022:
Awards Reserved for Issuance Awards Exercised Awards Outstanding Awards Available for Grant
2016 Equity Incentive Plan 999,906  —  499,953  499,953 
2018 Equity Incentive Plan 30,988,982  4,022,133  14,009,842  12,957,007 
2019 Equity Incentive Plan 109,990,468  34,884  73,014,714  36,940,870 
Share-based Payment Arrangement, Option, Activity
The following table summarizes the Company’s stock option activity and related information for the six months ended June 30, 2022:
Number of
Shares
Weighted-
Average Exercise
Price Per Share
Weighted-
Average
Remaining
Contractual
Life
Aggregate
Intrinsic
Value of
In-the-Money
Options
 
Options outstanding as of January 1, 2022 88,251,380 $ 0.20 
Granted 400,000  — 
Exercised (146,212) $ 0.08 
Forfeited (223,791) $ 0.15 
Expired (154,762) $ 0.34 
Options outstanding as of June 30, 2022
88,126,615 $ 0.20  8.3 years $ 33 
Options exercisable as of June 30, 2022
50,718,424 $ 0.24   7.4 years $ 50 
Share-based Payment Arrangement, Activity
The following table sets forth the total stock-based compensation expense resulting from stock options and restricted grants of common stock to employees, directors and non-employee consultants in the consolidated statement of operations which are included in selling, general and administrative expenses:
  (in thousands except for shares / options)
  For the Three Months Ended
  June 30, 2022 June 30, 2021
Type of Award Number of
Shares or
Options
Granted
Stock-Based
Compensation
Expense
Number of
Shares or
Options
Granted
Stock-Based
Compensation
Expense
 
Stock options 400,000 $ 1,352  5,409,716 $ 641 
Stock grants:
Employees (common stock) 1,200,000  $ 170  250,000 68 
Directors (common stock) 259,796 $ 29  343,493 94 
Non–employee consultants (common stock) 725,000 $ 129  — 
Total stock–based compensation expense $ 1,680  $ 803 
  (in thousands except for shares / options)
  For the Six Months Ended
  June 30, 2022 June 30, 2021
Type of Award Number of
Shares or
Options
Granted
Stock-Based
Compensation
Expense
Number of
Shares or
Options
Granted
Stock-Based
Compensation
Expense
 
Stock options 400,000 $ 3,174  5,909,716 $ 885 
Stock grants:
Employees (common stock) 2,100,000  $ 352  250,000 67 
Directors (common stock) 943,128 $ 213  885,159 214 
Non–employee consultants (common stock) 725,000 $ 129  332,947 32 
Total stock–based compensation expense $ 3,868  $ 1,198